Cargando…
Rethinking thresholds for serological evidence of influenza virus infection
INTRODUCTION: For pathogens such as influenza that cause many subclinical cases, serologic data can be used to estimate attack rates and the severity of an epidemic in near real time. Current methods for analysing serologic data tend to rely on use of a simple threshold or comparison of titres betwe...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410725/ https://www.ncbi.nlm.nih.gov/pubmed/28294578 http://dx.doi.org/10.1111/irv.12452 |
_version_ | 1783232741513363456 |
---|---|
author | Zhao, Xiahong Siegel, Karen Chen, Mark I‐Cheng Cook, Alex R. |
author_facet | Zhao, Xiahong Siegel, Karen Chen, Mark I‐Cheng Cook, Alex R. |
author_sort | Zhao, Xiahong |
collection | PubMed |
description | INTRODUCTION: For pathogens such as influenza that cause many subclinical cases, serologic data can be used to estimate attack rates and the severity of an epidemic in near real time. Current methods for analysing serologic data tend to rely on use of a simple threshold or comparison of titres between pre‐ and post‐epidemic, which may not accurately reflect actual infection rates. METHODS: We propose a method for quantifying infection rates using paired sera and bivariate probit models to evaluate the accuracy of thresholds currently used for influenza epidemics with low and high existing herd immunity levels, and a subsequent non‐influenza period. Pre‐ and post‐epidemic sera were taken from a cohort of adults in Singapore (n=838). Bivariate probit models with latent titre levels were fit to the joint distribution of haemagglutination‐inhibition assay‐determined antibody titres using Markov chain Monte Carlo simulation. RESULTS: Estimated attack rates were 15% (95% credible interval: 12%‐19%) for the first H1N1 pandemic wave. For a large outbreak due to a new strain, a threshold of 1:20 and a twofold rise (if pared sera is available) would result in a more accurate estimate of incidence. CONCLUSION: The approach presented here offers the basis for a reconsideration of methods used to assess diagnostic tests by both reconsidering the thresholds used and by analysing serological data with a novel statistical model. |
format | Online Article Text |
id | pubmed-5410725 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-54107252017-05-03 Rethinking thresholds for serological evidence of influenza virus infection Zhao, Xiahong Siegel, Karen Chen, Mark I‐Cheng Cook, Alex R. Influenza Other Respir Viruses Original Articles INTRODUCTION: For pathogens such as influenza that cause many subclinical cases, serologic data can be used to estimate attack rates and the severity of an epidemic in near real time. Current methods for analysing serologic data tend to rely on use of a simple threshold or comparison of titres between pre‐ and post‐epidemic, which may not accurately reflect actual infection rates. METHODS: We propose a method for quantifying infection rates using paired sera and bivariate probit models to evaluate the accuracy of thresholds currently used for influenza epidemics with low and high existing herd immunity levels, and a subsequent non‐influenza period. Pre‐ and post‐epidemic sera were taken from a cohort of adults in Singapore (n=838). Bivariate probit models with latent titre levels were fit to the joint distribution of haemagglutination‐inhibition assay‐determined antibody titres using Markov chain Monte Carlo simulation. RESULTS: Estimated attack rates were 15% (95% credible interval: 12%‐19%) for the first H1N1 pandemic wave. For a large outbreak due to a new strain, a threshold of 1:20 and a twofold rise (if pared sera is available) would result in a more accurate estimate of incidence. CONCLUSION: The approach presented here offers the basis for a reconsideration of methods used to assess diagnostic tests by both reconsidering the thresholds used and by analysing serological data with a novel statistical model. John Wiley and Sons Inc. 2017-04-26 2017-05 /pmc/articles/PMC5410725/ /pubmed/28294578 http://dx.doi.org/10.1111/irv.12452 Text en © 2017 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Zhao, Xiahong Siegel, Karen Chen, Mark I‐Cheng Cook, Alex R. Rethinking thresholds for serological evidence of influenza virus infection |
title | Rethinking thresholds for serological evidence of influenza virus infection |
title_full | Rethinking thresholds for serological evidence of influenza virus infection |
title_fullStr | Rethinking thresholds for serological evidence of influenza virus infection |
title_full_unstemmed | Rethinking thresholds for serological evidence of influenza virus infection |
title_short | Rethinking thresholds for serological evidence of influenza virus infection |
title_sort | rethinking thresholds for serological evidence of influenza virus infection |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410725/ https://www.ncbi.nlm.nih.gov/pubmed/28294578 http://dx.doi.org/10.1111/irv.12452 |
work_keys_str_mv | AT zhaoxiahong rethinkingthresholdsforserologicalevidenceofinfluenzavirusinfection AT siegelkaren rethinkingthresholdsforserologicalevidenceofinfluenzavirusinfection AT chenmarkicheng rethinkingthresholdsforserologicalevidenceofinfluenzavirusinfection AT cookalexr rethinkingthresholdsforserologicalevidenceofinfluenzavirusinfection |